Skip to main content

Milestone 14.J

Convene an advisory meeting of experts from the pharmaceutical industry, government, academia, the FDA, and the non-profit sector to advance rational drug repositioning and combination therapy based on translational bioinformatics and network pharmacology approaches and to explore opportunities for new public-private partnerships to facilitate drug rescue/repurposing and combination therapy. 

Success Criteria

  • Development of recommendations for rational repositioning and combination therapy development.

  • Development, negotiation, and implementation of appropriate agreements among the stakeholders involved in repositioning and combination therapy of drugs for AD and related dementias.

  • These agreements should address legal issues, intellectual property rights, and liability to expedite rigorous clinical testing of repurposed drugs.

Research Implementation Area
Public Private Partnerships
In Progress

Accomplishments/Implementation Activities

Funding Initiatives

Research Highlights

Relevant Recommendations